Patents by Inventor UMIT ALI KAYISLI

UMIT ALI KAYISLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND USES THEREOF FOR TREATMENT OF IDIOPATHIC PRETERM BIRTH
    Publication number: 20240082261
    Abstract: Disclosed are compositions and methods for delaying or preventing idiopathic preterm
    Type: Application
    Filed: November 6, 2023
    Publication date: March 14, 2024
    Inventors: Charles Lockwood, Ozlem Guzeloglu-Kayisli, Umit Ali Kayisli, Frederick Schatz
  • Compositions and uses thereof for treatment of idiopathic preterm birth
    Patent number: 11806356
    Abstract: Disclosed are compositions and methods for delaying or preventing idiopathic preterm birth.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: November 7, 2023
    Assignee: University of South Florida
    Inventors: Charles Lockwood, Ozlem Guzeloglu-Kayisli, Umit Ali Kayisli, Frederick Schatz
  • COMPOSITIONS AND USES THEREOF FOR TREATMENT OF IDIOPATHIC PRETERM BIRTH
    Publication number: 20220088032
    Abstract: Disclosed are compositions and methods for delaying or preventing idiopathic preterm birth.
    Type: Application
    Filed: September 20, 2021
    Publication date: March 24, 2022
    Inventors: Charles Lockwood, Ozlem Guzeloglu-Kayisli, Umit Ali Kayisli, Frederick Schatz
  • Use of CCL2 to inhibit abnormal uterine bleeding
    Patent number: 10653750
    Abstract: The present invention concerns compositions and methods for inhibition of abnormal uterine bleeding (AUB), such as that associated with use of long-acting progestin-only contraceptives (LAPCs). An aspect of the invention concerns compositions comprising chemokine (C-C motif) ligand 2 (CCL2), or a biologically active fragment thereof, which may administered to subjects for inhibition of AUB. Another aspect of the invention concerns methods for inhibiting AUB, comprising administering an effective amount of CCL2, or a biologically active fragment thereof, to a subject in need thereof. Another aspect of the invention concerns a kit for inhibiting AUB.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: May 19, 2020
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Charles Joseph Lockwood, Umit Ali Kayisli, Murat Basar, Ozlem Guzeloglu-Kayisli, Nihan Semerci, Frederick Schatz
  • USE OF CCL2 TO INHIBIT ABNORMAL UTERINE BLEEDING
    Publication number: 20180078615
    Abstract: The present invention concerns compositions and methods for inhibition of abnormal uterine bleeding (AUB), such as that associated with use of long-acting progestin-only contraceptives (LAPCs). An aspect of the invention concerns compositions comprising chemokine (C-C motif) ligand 2 (CCL2), or a biologically active fragment thereof, which may administered to subjects for inhibition of AUB. Another aspect of the invention concerns methods for inhibiting AUB, comprising administering an effective amount of CCL2, or a biologically active fragment thereof, to a subject in need thereof. Another aspect of the invention concerns a kit for inhibiting AUB.
    Type: Application
    Filed: March 23, 2016
    Publication date: March 22, 2018
    Inventors: CHARLES JOSEPH LOCKWOOD, UMIT ALI KAYISLI, MURAT BASAR, OZLEM GUZELOGLU-KAYISLI, NIHAN SEMERCI, FREDERICK SCHATZ